The Evolution of PEPFAR: Navigating a New Era in Global HIV Relief

For over two decades, the President’s Emergency Plan for AIDS Relief (PEPFAR) has stood as the most significant international commitment by any single nation to combat a specific disease. Since its inception in 2003, the program has played a pivotal role in shifting the trajectory of the global HIV epidemic, credited with saving an estimated 26 million lives. However, as of May 2026, the program is navigating a period of profound structural and strategic transformation.

A Legacy of Impact

PEPFAR was announced in 2003 and quickly became the cornerstone of U.S. Global health efforts. Through its history, the program has provided critical support for HIV prevention, treatment, and care, including antiretroviral therapy, pre-exposure prophylaxis (PrEP), and services to prevent mother-to-child transmission. By the end of fiscal year 2024, the program reported supporting antiretroviral treatment for 20.6 million people and providing testing services for 83.8 million individuals.

The program’s success has been supported by significant bipartisan commitment, with Congress appropriating over $130 billion since its founding. While the program’s formal authorization expired in March 2025, it remains a permanent fixture of U.S. Law, continuing to operate through annual congressional appropriations.

The Shift to the America First Global Health Strategy

The landscape of global health assistance has undergone a fundamental shift under the second Trump administration. Central to this change is the “America First Global Health Strategy,” which emphasizes a transition away from direct U.S. Implementation toward a model of integration within partner countries’ own health systems.

Key operational changes include:

• Transition of Authority: The management of PEPFAR activities has been increasingly centralized within the Department of State, with significant changes to the roles of historically key implementing agencies like USAID and the CDC.
• Bilateral Health Agreements: Future assistance is being structured through bilateral agreements that require partner nations to increase their own domestic investments while U.S. Funding is reduced over time.
• Scope Narrowing: Following a 2025 foreign aid review, the scope of PEPFAR activities was refined to focus on specific “life-saving” services, including HIV treatment, care, and certain prevention measures.

Current Global HIV Statistics

Despite progress, HIV remains a major global health challenge. According to 2024 data, approximately 40.8 million people are living with HIV worldwide. While 31.6 million people are currently receiving treatment, the epidemic continues to claim hundreds of thousands of lives annually, with 630,000 AIDS-related deaths reported in 2024.

Snapshot of the Global Epidemic (2024 Data)

• People living with HIV: 40.8 million
• New infections: 1.3 million
• AIDS-related deaths: 630,000
• People on treatment: 31.6 million

Funding and Future Outlook

In fiscal year 2026, U.S. Appropriations for PEPFAR totaled $6 billion. This funding is split between bilateral efforts ($4.7 billion) and multilateral contributions ($1.3 billion), the latter of which includes $1.25 billion for the Global Fund to Fight AIDS, Tuberculosis, and Malaria. The U.S. Remains the largest donor to the Global Fund, having contributed nearly $33 billion since 2001.

While the administration has announced commitments to expand access to long-acting injectable PrEP—aiming to reach 3 million people by 2028—the move toward integrating HIV services into national health systems and reducing U.S. Funding levels marks a departure from the program’s historical operational model. As these bilateral agreements take effect, the long-term impact on global HIV outcomes remains a subject of close observation by public health experts and policymakers alike.

Note: This article provides an overview of the current status of PEPFAR based on available government data and legislative records. For more detailed information on specific country-level agreements, consult the official Department of State global health policy resources.